Home › Funds › AYAL Capital Advisors Ltd › BIO

AYAL Capital Advisors Ltd position in BIO

BIO RAD LABS INC · Industrials

AYAL Capital Advisors Ltd reported holding 23,013 shares of BIO (BIO RAD LABS INC) in its Q3 2026 13F filing — a position valued at US$8.7M, representing 3.09% of its reported portfolio and ranking #6 among its reported holdings. AYAL Capital Advisors Ltd has disclosed BIO holdings in 5 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)23.01K sh
Reported value held$8.69M
Portfolio Weight3.09%
First reportedQ4 2024
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How AYAL Capital Advisors Ltd's BIO position evolved

AYAL Capital Advisors Ltd first disclosed a stake in BIO in Q4 2024 at 13,600 shares (US$4.5M). The position peaked in Q3 2026 at 23,013 shares, worth US$8.7M. Across 5 filings, AYAL Capital Advisors Ltd increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 23,013 shares valued at US$8.7M — an increase of 6,680 shares quarter over quarter.. Notable position changes include a 41% increase in Q3 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 13.60K $4.47M New
Q3 2025 17.50K $4.91M New
Q4 2025 20.00K $6.06M Add
Q2 2026 16.33K $4.80M New
Q3 2026 23.01K $8.69M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIO and 13F data

BIO (BIO RAD LABS INC) is a Industrials company. 27 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$927.5M), ARIEL INVESTMENTS, LLC (US$298.1M), EARNEST PARTNERS LLC (US$214.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIO

All BIO fund holders →

FAQ

How long has AYAL Capital Advisors Ltd held BIO?

AYAL Capital Advisors Ltd has disclosed BIO holdings in 5 of the last 8 reported quarters, going back to Q4 2024.

What is AYAL Capital Advisors Ltd's current position in BIO?

As of Q3 2026, AYAL Capital Advisors Ltd holds 23.01K shares of BIO (BIO RAD LABS INC), valued at $8.69M, representing 3.09% of its reported portfolio and ranking #6.

Has AYAL Capital Advisors Ltd been buying or selling BIO?

In the latest 13F filing (Q3 2026), AYAL Capital Advisors Ltd increased its position in BIO. The position peaked in Q3 2026 at 23.01K shares.

Which other funds hold BIO?

Other major institutional holders of BIO include First Eagle Investment Management, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.